IRIS Institutional Research Information System - OPENBS Open Archive UniBS

TABELLINI, GIOVANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.784
AS - Asia 3.197
EU - Europa 3.098
SA - Sud America 569
AF - Africa 55
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 8
Totale 12.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.699
CN - Cina 1.394
PL - Polonia 947
SG - Singapore 888
UA - Ucraina 562
BR - Brasile 483
FR - Francia 410
IT - Italia 291
HK - Hong Kong 280
DE - Germania 259
VN - Vietnam 210
FI - Finlandia 178
GB - Regno Unito 128
IN - India 121
RU - Federazione Russa 105
TR - Turchia 103
IE - Irlanda 90
CA - Canada 55
SE - Svezia 46
AR - Argentina 36
BD - Bangladesh 28
KR - Corea 26
ID - Indonesia 21
IQ - Iraq 19
AU - Australia 18
ZA - Sudafrica 18
NL - Olanda 16
SA - Arabia Saudita 16
MX - Messico 15
JP - Giappone 14
EC - Ecuador 13
AT - Austria 12
BE - Belgio 12
ES - Italia 11
NG - Nigeria 11
CO - Colombia 8
CZ - Repubblica Ceca 8
PK - Pakistan 8
VE - Venezuela 8
EG - Egitto 7
IR - Iran 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
CL - Cile 6
EU - Europa 6
MA - Marocco 6
PE - Perù 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
KZ - Kazakistan 5
LT - Lituania 5
OM - Oman 5
PH - Filippine 5
IL - Israele 4
LB - Libano 4
MU - Mauritius 4
MY - Malesia 4
CH - Svizzera 3
CR - Costa Rica 3
DZ - Algeria 3
GT - Guatemala 3
HN - Honduras 3
JM - Giamaica 3
JO - Giordania 3
LV - Lettonia 3
TN - Tunisia 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
IM - Isola di Man 2
KG - Kirghizistan 2
MN - Mongolia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MK - Macedonia 1
NI - Nicaragua 1
RS - Serbia 1
SI - Slovenia 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 12.729
Salva come PNG Salva come JPEG
Città #
Warsaw 945
Fairfield 722
Woodbridge 552
Ashburn 503
Singapore 467
Houston 436
Shenzhen 408
Jacksonville 396
Hong Kong 277
Cambridge 274
Seattle 268
Wilmington 266
Ann Arbor 245
Beijing 233
San Jose 215
The Dalles 183
Princeton 166
Brescia 152
New York 150
Chandler 133
Nanjing 118
Helsinki 93
Dublin 87
Los Angeles 80
Dearborn 79
Lauterbourg 75
Istanbul 71
Nanchang 69
Ho Chi Minh City 63
Moscow 51
Shenyang 46
São Paulo 46
Des Moines 38
Milan 38
San Diego 38
Buffalo 37
Dallas 37
Hanoi 37
Council Bluffs 36
Munich 36
Changsha 35
Hebei 32
Jinan 31
San Francisco 31
Chicago 28
London 27
Tianjin 27
Redondo Beach 26
Dong Ket 24
Montreal 24
Jiaxing 22
Shanghai 22
Ningbo 20
Orem 20
Taizhou 20
Santa Clara 19
Seongnam 19
Toronto 19
Denver 15
Jakarta 15
Rio de Janeiro 15
Chennai 14
Kunming 14
Turku 14
Zhengzhou 14
Brasília 13
Indianapolis 13
Kocaeli 13
Tokyo 13
Augusta 12
Phoenix 12
Verona 12
Abuja 11
Haiphong 10
Hangzhou 10
Riyadh 10
Atlanta 9
Brooklyn 9
Brussels 9
Johannesburg 9
Stockholm 9
Amsterdam 8
Baghdad 8
Campinas 8
Da Nang 8
Haikou 8
Mumbai 8
Nuremberg 8
Charlotte 7
Frankfurt am Main 7
Lancaster 7
Manchester 7
Quito 7
Salvador 7
Sydney 7
Tashkent 7
Vienna 7
Washington 7
Baku 6
Belo Horizonte 6
Totale 9.025
Salva come PNG Salva come JPEG
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 577
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 384
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 379
NFKB1 regulates human NK cell maturation and effector functions 333
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. 314
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 292
Targeting the PI3K/Akt/mTOR signaling pathway in B-precursor acute lymphoblastic leukemia and its therapeutic potential 284
Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. 252
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 227
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 219
CTLA-4 regulates human Natural Killer cell effector functions 206
The RAC2-PI3K axis regulates human NK cell maturation and function 206
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 201
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 192
Effects of opioid therapy on human natural killer cells. 185
Inherited DOCK2 deficiency in patients with early-onset invasive infections 184
A threonine 308 phosphorylated form of Akt translocates to the nucleus of PC12 cells under nerve growth factor stimulation and associates with the nuclear matrix protein nucleolin. 168
Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway. 165
A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. 158
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 154
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 154
Phosphoinositide 3-kinase/Akt inhibition increases arsenic trioxide-induced apoptosis of acute promyelocytic and T-cell leukaemias 151
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 150
Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: eliminating activity by targeting at different levels 147
Rab3A and Rab3D control the total granule number and the fraction of granules docked at the plasma membrane in PC12 cells 145
Re-examination of the mechanisms regulating nuclear inositol lipid metabolism. 145
Flow cytometric detection of total and serine 473 phosphorylated Akt. 145
Diacylglycerol kinases in nuclear lipid-dependent signal transduction pathways 144
Cytotoxic activity of the casein kinase 2 inhibitor CX-4945 against T-cell acute lymphoblastic leukemia: Targeting the unfolded protein response signaling 142
Proliferating or differentiating stimuli act on different lipid-dependent signaling pathways in nuclei of human leukemia cells. 141
Nuclear changes in necrotic HL-60 cells. 136
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 135
The emerging multiple roles of nuclear Akt 134
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 134
Influence of different metal ions on the ultrastructure, biochemical properties, and protein localization of the K562 cell nuclear matrix. 133
Intranuclear distribution of HMGI/Y proteins. An immunocytochemical study 133
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 132
Phosphoinositide 3-kinase/Akt involvement in arsenic trioxide resistance of human leukemia cells. 130
The insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 induces apoptosis in acute myeloid leukemia cells exhibiting autocrine insulin-like growth factor-I secretion. 129
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 129
The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. 128
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia. 128
Nuclear apoptotic changes: an overview 127
Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation. 127
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. 127
Activity of the novel mTOR inhibitor Torin-2 in B-precursor acute lymphoblastic leukemia and its therapeutic potential to prevent Akt reactivation 127
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 127
Localization of the small monomeric GTPases Rab3D and Rab3A in the AtT-20 rat pituitary cell line. 126
The novel dual PI3K/mTOR inhibitor NVP-BGT226 displays cytotoxic activity in both normoxic and hypoxic hepatocarcinoma cells 126
Nuclear lipids: new functions for old molecules? 125
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 125
Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study 121
PI3K/AKT/mTORC1 and MEK/ERK signaling in T-cell acute lymphoblastic leukemia: New options for targeted therapy. 120
Novel 2'-substituted, 3'-deoxy-phosphatidyl-myo-inositol analogues reduce drug resistance in human leukaemia cell lines with an activated phosphoinositide 3-kinase/Akt pathway. 119
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 119
Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor Perifosine in acute myelogenous leukemia cells. 118
Further considerations on the intranuclear distribution of HMGI/Y proteins. 117
Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia 116
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 113
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 113
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 111
P85α is an intrinsic regulator of human natural killer cell effector functions 111
Diacylglycerol kinase-theta is localized in the speckle domains of the nucleus. 108
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 106
The pro-apoptotic drug camptothecin stimulates phospholipase D activity and diacylglycerol production in the nucleus of HL-60 human promyelocytic leukemia cells. 106
Activity of the selective IκB kinase inhibitor BMS-345541 against T-cell acute lymphoblastic leukemia: Involvement of FOXO3a. 106
The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. 104
Phosphoinositide-specific phospholipase Cbeta1 expression is not linked to nerve growth factor-induced differentiation, cell survival or cell cycle control in PC12 rat pheocromocytoma cells. 102
Enhanced nuclear diacylglycerol kinase activity in response to a mitogenic stimulation of quiescent Swiss 3T3 cells with insulin-like growth factor I. 101
The controversial nuclear matrix: a balanced point of view. 101
Involvement of the phosphoinositide 3-kinase/Akt signaling pathway in the resistance to therapeutic treatments of human leukemias. 100
Binding of elements of protein kinase C-alpha regulatory domain to lamin B1 98
Natural killer cell impairment in ovarian clear cell carcinoma 98
Nuclear expression of diacylgycerol kinases: possibile involvement in DNA replication 94
Molecular characterization of protein kinase C-alpha binding to lamin A. 91
Rabphilin localizes with the cell actin cytoskeleton and stimulates association of granules with F-actin cross-linked by {alpha}-actinin. 91
Intranucleolar localization of DNA topoisomerase IIalpha is a distinctive feature of necrotic, but not of apoptotic, Jurkat T-cells. 91
Erythropoietin-induced erythroid differentiation of K562 cells is accompanied by the nuclear translocation of phosphatidylinositol 3-kinase and intranuclear generation of phosphatidylinositol (3,4,5) trisphosphate. 91
Nuclear matrix protein is released from apoptotic white cells during cold (1-6 degrees C) storage of concentrated red cell units and might induce antibody response in multiply transfused patients. 90
Nuclear phosphoinositide specific phospholipase C (PI-PLC)-beta 1: a central intermediary in nuclear lipid-dependent signal transduction. 88
Nuclear diacylglycerol kinases: emerging downstream regulators in cell signaling networks. 87
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 87
Nuclear diacylglycerol kinase-theta is activated in response to nerve growth factor stimulation of PC12 cells. 84
FGF-trapping hampers cancer stem-like cells in uveal melanoma 83
Insulin-like growth factor-I-dependent stimulation of nuclear phospholipase C-beta1 activity in Swiss 3T3 cells requires an intact cytoskeleton and is paralleled by increased phosphorylation of the phospholipase. 82
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 81
Remission Status at Transplantation and Treatment History Determine the Survival Chances of Patients after Allogeneic Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia Who Had Received Pre-Treatment with Idelalisib: A Report from the EBMT Chronic Malignancies Working Party 65
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 21
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 21
Totale 12.917
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.577
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.577
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021358 0 0 0 0 0 0 0 0 0 130 168 60
2021/2022827 61 158 21 56 15 32 38 50 34 97 66 199
2022/2023519 125 1 3 31 33 146 5 52 59 1 28 35
2023/20241.004 36 11 462 27 17 130 32 25 163 2 8 91
2024/20251.405 11 3 6 184 155 110 119 48 158 113 332 166
2025/20262.902 269 395 260 515 306 178 411 160 199 209 0 0
Totale 12.917